287 related articles for article (PubMed ID: 18301941)
41. Categorizing Cannabis and Alcohol Use Patterns of Emerging Adults in Psychiatric Partial Hospitalization Treatment.
Blevins CE; Grimone KR; Caviness CM; Stein MD; Abrantes AM
J Psychiatr Pract; 2019 Nov; 25(6):491-498. PubMed ID: 31821229
[TBL] [Abstract][Full Text] [Related]
42. [Cannabis cessation interventions offered to young French users: predictors of follow-up].
Abdoul H; Le Faou AL; Bouchez J; Touzeau D; Lagrue G
Encephale; 2012 Apr; 38(2):141-8. PubMed ID: 22516272
[TBL] [Abstract][Full Text] [Related]
43. Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study.
Fatseas M; Serre F; Swendsen J; Auriacombe M
Drug Alcohol Depend; 2018 Jun; 187():242-248. PubMed ID: 29684892
[TBL] [Abstract][Full Text] [Related]
44. [Clinical and prognostic characteristics associated with addictive comorbidity in hospitalized psychiatric patients].
Liraud F; Verdoux H
Encephale; 2000; 26(3):16-23. PubMed ID: 10951902
[TBL] [Abstract][Full Text] [Related]
45. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
[TBL] [Abstract][Full Text] [Related]
46. Consequences of receipt of a psychiatric diagnosis for completion of college.
Hunt J; Eisenberg D; Kilbourne AM
Psychiatr Serv; 2010 Apr; 61(4):399-404. PubMed ID: 20360280
[TBL] [Abstract][Full Text] [Related]
47. DSM-III-R alcohol abuse and dependence and psychiatric comorbidity in Ontario: results from the Mental Health Supplement to the Ontario Health Survey.
Ross HE
Drug Alcohol Depend; 1995 Aug; 39(2):111-28. PubMed ID: 8529531
[TBL] [Abstract][Full Text] [Related]
48. Multimethod alexithymia assessment in adolescents and young adults with a cannabis use disorder.
Dorard G; Berthoz S; Haviland MG; Phan O; Corcos M; Bungener C
Compr Psychiatry; 2008; 49(6):585-92. PubMed ID: 18970907
[TBL] [Abstract][Full Text] [Related]
49. Profiles and mental health correlates of alcohol and illicit drug use in the Canadian population: an exploration of the J-curve hypothesis.
Dumais A; De Benedictis L; Joyal C; Allaire JF; Lesage A; Côté G
Can J Psychiatry; 2013 Jun; 58(6):344-52. PubMed ID: 23768262
[TBL] [Abstract][Full Text] [Related]
50. Interictal dysphoric disorder in patients with localization-related epilepsy: Diagnostic relationships with DSM-IV psychiatric disorders and the impact of psychosocial burden.
Suda T; Tatsuzawa Y; Mogi T; Yoshino A
Epilepsy Behav; 2016 Jan; 54():142-7. PubMed ID: 26708065
[TBL] [Abstract][Full Text] [Related]
51. Depression and psychological distress in tobacco smokers and people with cannabis dependence in the National Survey of Mental Health and Wellbeing.
Mathews RR; Hall WD; Gartner CE
Med J Aust; 2011 Aug; 195(3):S12-5. PubMed ID: 21806512
[TBL] [Abstract][Full Text] [Related]
52. Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment.
Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
J Subst Abuse Treat; 2007 Mar; 32(2):113-9. PubMed ID: 17306720
[TBL] [Abstract][Full Text] [Related]
53. The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being.
Degenhardt L; Hall W; Lynskey M
Soc Psychiatry Psychiatr Epidemiol; 2001 May; 36(5):219-27. PubMed ID: 11515699
[TBL] [Abstract][Full Text] [Related]
54. Comorbidity of select anxiety and affective disorders with alcohol dependence in southwest California Indians.
Gilder DA; Wall TL; Ehlers CL
Alcohol Clin Exp Res; 2004 Dec; 28(12):1805-13. PubMed ID: 15608596
[TBL] [Abstract][Full Text] [Related]
55. Higher smoking prevalence among United States adults with co-occurring affective and drug use diagnoses.
Parker MA; Sigmon SC; Villanti AC
Addict Behav; 2019 Dec; 99():106112. PubMed ID: 31476691
[TBL] [Abstract][Full Text] [Related]
56. [Cannabis and schizophrenia: demographic and clinical correlates].
Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
[TBL] [Abstract][Full Text] [Related]
57. Alexithymia in substance abuse: relationship to depression.
Fukunishi I
Psychol Rep; 1996 Apr; 78(2):641-2. PubMed ID: 9148322
[TBL] [Abstract][Full Text] [Related]
58. Alexithymia, affect recognition, and five factors of personality in substance abusers.
Mann LS; Wise TN; Trinidad A; Kohanski R
Percept Mot Skills; 1995 Aug; 81(1):35-40. PubMed ID: 8532477
[TBL] [Abstract][Full Text] [Related]
59. Assessing advanced theory of mind and alexithymia in patients suffering from enduring borderline personality disorder.
Pluta A; Kulesza M; Grzegorzewski P; Kucharska K
Psychiatry Res; 2018 Mar; 261():436-441. PubMed ID: 29360051
[TBL] [Abstract][Full Text] [Related]
60. [Alexithymia, depression and drug addiction].
F farges ; Corcos M; Speranza M; Loas G; Perez-Diaz F; Venisse JL; Lang F; Bizouard P; Halfon O; Flament M; Jeammet P
Encephale; 2004; 30(3):201-11. PubMed ID: 15235517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
